Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $30.10 Analyst target: $63.07 Upside: 109.53%
Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.